J A Govaert1, M Fiocco2, W A van Dijk3, A C Scheffer4, E J R de Graaf5, R A E M Tollenaar6, M W J M Wouters7. 1. Leiden University Medical Center, Department of Surgery, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; Groene Hart Ziekenhuis, Department of Surgery, Bleulandweg 10, 2803 HH Gouda, The Netherlands. Electronic address: J.A.Govaert@lumc.nl. 2. Leiden University Medical Center, Department of Medical Statistics and Bioinformatics, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; Leiden University Mathematical Institute, Niels Bohrweg 1, 233 CA Leiden, The Netherlands. 3. Performation, Sweelincklaan 1, 3723 JA Bilthoven, The Netherlands; X-is, Vrouwjuttenland 13, 2611 LB Delft, The Netherlands. 4. Performation, Sweelincklaan 1, 3723 JA Bilthoven, The Netherlands. 5. IJsselland Hospital, Capelle aan den IJssel, Department of Surgery, Prins Constantijnweg 2, 2906 ZC Capelle aan den IJssel, The Netherlands. 6. Leiden University Medical Center, Department of Surgery, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. 7. Leiden University Medical Center, Department of Surgery, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Department of Surgical Oncology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Abstract
BACKGROUND: Healthcare providers worldwide are struggling with rising costs while hospitals budgets are under stress. Colorectal cancer surgery is commonly performed, however it is associated with a disproportionate share of adverse events in general surgery. Since adverse events are associated with extra hospital costs it seems important to explicitly discuss the costs of complications and the risk factors for high-costs after colorectal surgery. METHODS: Retrospective analysis of clinical and financial outcomes after colorectal cancer surgery in 29 Dutch hospitals (6768 patients). Detailed clinical data was derived from the 2011-2012 population-based Dutch Surgical Colorectal Audit database. Costs were measured uniform in all participating hospitals and based on Time-Driven Activity-Based Costing. FINDINGS: Of total hospital costs in this study, 31% was spent on complications and the top 5% most expensive patients were accountable for 23% of hospitals budgets. Minor and severe complications were respectively associated with a 26% and 196% increase in costs as compared to patients without complications. Independent from other risk factors, ASA IV, double tumor, ASA III, short course preoperative radiotherapy and TNM-4 stadium disease were the top-5 attributors to high costs. CONCLUSIONS: This article shows that complications after colorectal cancer surgery are associated with a substantial increase in costs. Although not all surgical complications can be prevented, reducing complications will result in considerable cost savings. By providing a business case we show that investments made to develop targeted quality improvement programs will pay off eventually. Results based on this study should encourage healthcare providers to endorse quality improvement efforts.
BACKGROUND: Healthcare providers worldwide are struggling with rising costs while hospitals budgets are under stress. Colorectal cancer surgery is commonly performed, however it is associated with a disproportionate share of adverse events in general surgery. Since adverse events are associated with extra hospital costs it seems important to explicitly discuss the costs of complications and the risk factors for high-costs after colorectal surgery. METHODS: Retrospective analysis of clinical and financial outcomes after colorectal cancer surgery in 29 Dutch hospitals (6768 patients). Detailed clinical data was derived from the 2011-2012 population-based Dutch Surgical Colorectal Audit database. Costs were measured uniform in all participating hospitals and based on Time-Driven Activity-Based Costing. FINDINGS: Of total hospital costs in this study, 31% was spent on complications and the top 5% most expensive patients were accountable for 23% of hospitals budgets. Minor and severe complications were respectively associated with a 26% and 196% increase in costs as compared to patients without complications. Independent from other risk factors, ASA IV, double tumor, ASA III, short course preoperative radiotherapy and TNM-4 stadium disease were the top-5 attributors to high costs. CONCLUSIONS: This article shows that complications after colorectal cancer surgery are associated with a substantial increase in costs. Although not all surgical complications can be prevented, reducing complications will result in considerable cost savings. By providing a business case we show that investments made to develop targeted quality improvement programs will pay off eventually. Results based on this study should encourage healthcare providers to endorse quality improvement efforts.
Authors: Niklas N Baastrup; Morten F S Hartwig; Peter-Martin Krarup; Lars N Jorgensen; Kristian K Jensen Journal: World J Surg Date: 2019-04 Impact factor: 3.352
Authors: Javier Ripollés-Melchor; José M Ramírez-Rodríguez; Rubén Casans-Francés; César Aldecoa; Ane Abad-Motos; Margarita Logroño-Egea; José Antonio García-Erce; Ángels Camps-Cervantes; Carlos Ferrando-Ortolá; Alejandro Suarez de la Rica; Ana Cuellar-Martínez; Sandra Marmaña-Mezquita; Alfredo Abad-Gurumeta; José M Calvo-Vecino Journal: JAMA Surg Date: 2019-08-01 Impact factor: 14.766
Authors: Annefleur E M Berkel; Laura van Wijk; David P J van Dijk; Sanne N Prins; Job van der Palen; Nico L U van Meeteren; Steven W M Olde Damink; Joost M Klaase; Bart C Bongers Journal: Colorectal Dis Date: 2021-10-20 Impact factor: 3.917
Authors: Babak Rashidi; Daniel M Kobewka; David J T Campbell; Alan J Forster; Paul E Ronksley Journal: BMC Health Serv Res Date: 2017-11-25 Impact factor: 2.655
Authors: Wenhao Man; Huajun Lin; Zhao Liu; Lei Jin; Jin Wang; Jun Zhang; Zhigang Bai; Hongwei Yao; Zhongtao Zhang; Wei Deng Journal: Cancer Manag Res Date: 2020-02-11 Impact factor: 3.989
Authors: Tom van den Bosch; Anne-Loes K Warps; Michael P M de Nerée Tot Babberich; Christina Stamm; Bart F Geerts; Louis Vermeulen; Michel W J M Wouters; Jan Willem T Dekker; Rob A E M Tollenaar; Pieter J Tanis; Daniël M Miedema Journal: JAMA Netw Open Date: 2021-04-01
Authors: Stijn C Voeten; Michel W J M Wouters; Franka S Würdemann; Pieta Krijnen; Inger B Schipper; J H Hegeman Journal: Arch Osteoporos Date: 2021-04-08 Impact factor: 2.617
Authors: Annefleur E M Berkel; Bart C Bongers; Hayke Kotte; Paul Weltevreden; Frans H C de Jongh; Michiel M M Eijsvogel; Machteld Wymenga; Marloes Bigirwamungu-Bargeman; Job van der Palen; Marc J van Det; Nico L U van Meeteren; Joost M Klaase Journal: Ann Surg Date: 2022-02-01 Impact factor: 13.787
Authors: Dieuwertje E Kok; Melissa N N Arron; Tess Huibregtse; Flip M Kruyt; Dirk Jan Bac; Henk K van Halteren; Ewout A Kouwenhoven; Evertine Wesselink; Renate M Winkels; Moniek van Zutphen; Fränzel J B van Duijnhoven; Johannes H W de Wilt; Ellen Kampman Journal: JAMA Surg Date: 2021-06-16 Impact factor: 16.681